Scandinavian ChemoTech AB (publ) Year-End Report January – December 2023 - Executive Summary
Fourth quarter · Net sales amounted to kSEK 507 (227) · Profit before tax amounted to kSEK -5 148 (-6 497) · Earnings per share amounted to SEK -0,35 (-0,59) · Cash flow from operating activities totaled to kSEK -3 396 (-5 208) Period 1 januari - 31 december 2023 · Net sales amounted to kSEK 2 822 (473) · Profit before tax amounted to kSEK -21 091 (-22 746) · Earnings per share amounted to SEK -1,56 (-2,28) · Cash flow from operating activities totaled to kSEK -9 135 (-6 414) · Kassan uppgick till 923 KSEK (5 852) · The order book amounted to approx.